Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123 × CD3 bispecific Dart® molecule, in patients with relapsed/refractory acute myeloid leukemia

Rutella, S. ORCID: 0000-0003-1970-7375, Church, S.E., Vadakekolathu, J., Viboch, E., Sullivan, A.H., Hood, T., Warren, S.E., Cesano, A., La Motte-Mohs, R., Muth, J., Lelièvre, H., Lowenberg, B., DiPersio, J.F. and Davidson-Moncada, J.K., 2018. Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123 × CD3 bispecific Dart® molecule, in patients with relapsed/refractory acute myeloid leukemia. Blood, 132 (S1): 444. ISSN 0006-4971

Full text not available from this repository.
Item Type: Journal article
Publication Title: Blood
Creators: Rutella, S., Church, S.E., Vadakekolathu, J., Viboch, E., Sullivan, A.H., Hood, T., Warren, S.E., Cesano, A., La Motte-Mohs, R., Muth, J., Lelièvre, H., Lowenberg, B., DiPersio, J.F. and Davidson-Moncada, J.K.
Publisher: American Society of Hematology
Date: 29 November 2018
Volume: 132
Number: S1
ISSN: 0006-4971
Identifiers:
NumberType
10.1182/blood-2018-99-111539DOI
Divisions: Schools > School of Science and Technology
Depositing User: Linda Sullivan
Date Added: 19 Dec 2018 09:57
Last Modified: 03 Sep 2019 15:18
Related URLs:
URI: http://irep.ntu.ac.uk/id/eprint/35385

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year